IVF Instantâneo da Ação
Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$1.19
Capitalização de Mercado
—
P/E (TTM)
-0.0
EPS (TTM)
$-214.64
Receita (TTM)
$7M
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$0 – $5
IVF Gráfico de Preço da Ação
OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Médias móveis e sobreposições
Volume
Osciladores
Momento e tendência
Configure
Desempenho de 10 Anos
Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido$7M
2022-12-31→2025-12-31
EPS$-214.64
2022-12-31→2025-12-31
Fluxo de caixa livre—
2023-12-31→2023-12-31
Margens—
Avaliação
Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
P/E (TTM)
-0.0
27.5
Lucratividade
Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
Saúde financeira
Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
Crescimento
Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
4.7%
—
Revenue CAGR 3Y (CAGR Receita 3A)
102.6%
—
Revenue CAGR 5Y (CAGR Receita 5A)
45.8%
—
Métricas por Ação
EPS, valor patrimonial por ação, fluxo de caixa por ação, dividendo por ação
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
EPS (Diluted) (EPS (Diluído))
$-214.64
—
Eficiência de Capital
Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
IVF
Mediana de Pares
IVF Consenso dos analistas
Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA5 analistas
Compra forte
120,0%
Compra
360,0%
Manter
120,0%
Venda
00,0%
Venda forte
00,0%
Preço-alvo de 12 meses
1 analistas
· 2026-08-19
Mín$20.00
Máx$20.00
Alvo mediano$20.00
+1587,8%
Alvo médio$20.00
+1587,8%
Histórico de Lucros
EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-719.3%
Período
EPS Actual
EPS est.
Surpresa
31 de Março de 2026
$-3.38
$-1.26
-2.1%
31 de Dezembro de 2025
$-196.81
$-2.78
-194.0%
30 de Setembro de 2025
$-0.77
$-0.04
-0.73%
31 de Dezembro de 2024
$-3104.40
$-424.20
-2680.2%
30 de Setembro de 2023
$-0.70
—
—
30 de Junho de 2023
$-3.06
—
—
Comparação de pares (subindústria GICS)
Métricas chave vs pares do setor
Ticker
Capitalização de Mercado
P/E
Receita YoY
Margem Líquida
ROE
Margem Bruta
IVF
—
-0.0
4.7%
—
—
—
GCTK
$4M
0.1
—
—
-399.4%
—
TNON
—
—
—
—
—
—
AEMD
$3M
-0.2
—
—
-134.5%
—
ABT
$250.18B
33.7
5.7%
14.7%
13.1%
—
Fundamentos Completos
Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados18
Dados anuais de Demonstração de Resultados para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$7M
$7M
$3M
$822.2K
$4M
$1M
$1M
$494.4K
$282.1K
$50.9K
$11.7K
$16.6K
Cost of Revenue
$30.6K
$12.2K
$2M
$286.9K
$126.3K
$79.0K
$133.7K
$90.4K
$52.0K
$15.1K
$7.8K
·
Gross Profit
·
·
·
$490.7K
$4M
$948.5K
$1M
$404.0K
$230.2K
$35.8K
$3.9K
$8.9K
R&D Expense
·
$4.9K
$165.9K
$544.0K
$216.4K
$398.4K
$0
·
·
·
·
·
SG&A Expense
$8M
$8M
$7M
$10M
$9M
$6M
$3M
$3M
$870.6K
$2M
$599.0K
$2M
Operating Expenses
$14M
$13M
$10M
$11M
$9M
$6M
$3M
$3M
$870.6K
$2M
$599.0K
$2M
Operating Income
$-7M
$-7M
$-7M
$-11M
$-5M
$-6M
$-2M
$-3M
$-640.4K
$-2M
$-595.1K
$-2M
Interest Expense
·
$1M
$925.9K
$59.4K
$1M
$3M
$387.6K
$442.0K
$20.9K
$13.8K
$32.0K
$51.9K
Interest Income
·
·
·
·
·
$4.2K
$8.6K
·
·
·
·
·
Other Non-op
$2M
$-972.0K
$-1M
$-263.2K
$-1M
$-3M
$-379.0K
$-442.0K
$-61.7K
·
·
·
Pretax Income
$-5M
$-8M
$-8M
$-11M
$-7M
$-8M
$-2M
$-3M
$-702.2K
$-2M
$-5M
$-2M
Income Tax
$-150.4K
$140.2K
$27.8K
$2.9K
$4.8K
$36
$433
$0
$0
$0
$0
$0
Net Income
$-23M
$-9M
$-8M
$-11M
$-7M
$-8M
$-2M
$-3M
$-702.2K
$-2M
$-5M
$-2M
EPS (Basic)
$-214.64
$-3782.65
$-67.37
$-17.97
$-0.63
$-1.52
$-0.45
$-0.02
$0.00
$-0.02
$-0.04
$-0.02
EPS (Diluted)
$-214.64
$-3782.65
$-67.37
$-17.97
$-0.63
$-1.52
$-0.45
$-0.02
$0.00
$-0.02
$-0.04
$-0.02
Shares (Basic)
117,083
2,514
119,264
606,130
10,632,413
5,489,738
4,854,878
147,333,051
141,305,050
139,186,557
128,567,615
112,672,160
Shares (Diluted)
117,083
2,514
119,264
606,130
10,632,413
5,489,738
4,854,878
147,333,051
141,305,050
139,186,557
128,567,615
112,672,160
EBITDA
·
·
$-7M
·
·
·
$-2M
·
$-637.6K
$-2M
$-589.4K
·
Balanço Patrimonial25
Dados anuais de Balanço Patrimonial para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$2M
$619.5K
$232.4K
$90.1K
$6M
$10M
$1M
$212.2K
$25.8K
$152.4K
$492.0K
$18.6K
Receivables
$217.3K
$113.1K
$140.6K
$77.1K
$50.5K
$21.7K
$7.6K
$225.9K
$86.7K
$2.8K
$1.3K
$321
Inventory
$225.3K
$219.8K
$264.5K
$263.6K
$287.8K
$265.4K
$101.4K
$43.5K
$58.9K
$85.2K
$65.4K
$62.5K
Prepaid Expense
$241.1K
$180.9K
$622.3K
$190.2K
$282.8K
$157.7K
$195.9K
$249.5K
$63.0K
$11.0K
$0
$0
Current Assets
$3M
$1M
$1M
$621.1K
$6M
$11M
$2M
$731.1K
$234.4K
$251.4K
$558.8K
$81.4K
PP&E (Net)
$386.2K
$466.7K
$826.4K
$436.7K
$501.4K
$132.2K
$93.1K
$34.4K
$15.7K
$15.7K
$0
$0
Accum. Depreciation
$459.6K
$335.7K
$233.6K
$153.3K
$78.2K
$52.3K
$42.1K
$35.9K
·
·
·
·
Goodwill
$6M
$6M
$6M
·
·
·
·
·
·
·
·
·
Intangibles
$1M
$3M
$4M
·
$132.1K
$95.0K
$7.2K
$11.8K
$16.3K
$19.1K
$21.0K
$26.6K
Other Non-current Assets
·
·
·
·
·
$272.6K
$159.0K
$11.8K
$16.3K
$19.1K
$21.0K
$26.6K
Total Assets
$20M
$46M
$19M
$4M
$10M
$11M
$2M
$777.3K
$266.4K
$286.2K
$579.8K
$108.1K
Accounts Payable
$2M
$3M
$2M
$1M
$443.4K
$328.9K
$371.5K
$571.8K
$960.7K
$974.9K
$1M
$1M
Short-term Debt
·
·
·
$100.0K
·
$157.6K
$0
$131.7K
$0
·
·
·
Current Liabilities
$10M
$18M
$8M
$3M
$1M
$2M
$2M
$4M
$5M
$5M
$4M
$4M
Capital Leases
$1M
$1M
$3M
$1M
$2M
$58.6K
$81.5K
$0
·
·
·
·
Deferred Tax
·
$163.1K
·
$1.9K
$1.1K
$469
$433
$0
·
·
·
·
Total Liabilities
$13M
$26M
$18M
$5M
$3M
$5M
$6M
$4M
$5M
$5M
$4M
$4M
Long-term Debt
$892.5K
$7M
·
·
·
·
·
·
·
·
·
·
Total Debt
·
·
·
·
·
·
$0
·
·
·
·
·
Common Stock
$239
$37
$20
$61
$1.2K
$964
$489
$15.4K
$14.2K
$14.1K
$13.7K
$12.0K
Paid-in Capital
·
·
·
·
$46M
$38M
$20M
$19M
$14M
$13M
$12M
$6M
Retained Earnings
$-91M
$-67M
$-58M
$-50M
$-39M
$-32M
$-24M
$-22M
$-19M
$-18M
$-16M
$-11M
Stockholders' Equity
$7M
$13M
$892.8K
$-977.6K
$7M
$6M
$-4M
$-3M
$-5M
$-5M
$-4M
$-4M
Liabilities + Equity
$20M
$46M
$19M
$4M
$10M
$11M
$2M
$777.3K
$266.4K
$286.2K
$579.8K
$108.1K
Shares Outstanding
477,366
3,111
207,711
608,611
11,929,147
9,639,268
4,884,879
4,821,641
142,132,374
140,596,646
137,085,646
119,732,270
Fluxo de Caixa15
Dados anuais de Fluxo de Caixa para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
D&A
$677.4K
$919.6K
$200.9K
$77.3K
$27.8K
$11.9K
$10.8K
$5.2K
$2.8K
$1.9K
$5.6K
$10.5K
Stock-based Comp
$162.9K
·
·
$2M
$2M
$1M
$69.8K
$0
·
·
·
·
Deferred Tax
·
·
·
·
·
·
·
·
·
$0
$0
$0
Amort. of Intangibles
$553.4K
$817.5K
$120.6K
$1.8K
$1.8K
$1.8K
$4.6K
·
·
·
·
·
Other Non-cash
·
·
$3M
·
·
·
$3M
·
$518.1K
$2M
$5M
·
Operating Cash Flow
$-7M
$-3M
$-5M
$-7M
$-6M
$-5M
$1M
$-653.0K
$-181.3K
$-323.9K
$-151.6K
$-19.4K
CapEx
$43.4K
$183.7K
$444.7K
$10.8K
$415.7K
$49.3K
$64.8K
$19.4K
$0
$15.7K
$0
·
Investing Cash Flow
$-3M
$363.9K
$-2M
$-81.2K
$-2M
$-187.3K
$-114.7K
$-19.4K
$0
$-15.7K
$0
·
Stock Issued
$12M
$165.1K
$6M
$289.8K
$4M
$11M
$0
$47.0K
$54.6K
$0
$645.0K
$20.0K
Net Stock Activity
·
·
$6M
·
·
·
$0
·
$54.6K
$0
$645.0K
·
Financing Cash Flow
$11M
$3M
$7M
$1M
$4M
$14M
$-229.5K
$858.9K
$54.6K
$0
$625.0K
$20.0K
Net Change in Cash
$1M
$509.0K
$142.3K
$-6M
$-4M
$9M
·
$186.5K
$-126.6K
$-339.6K
$473.4K
$599
Taxes Paid
·
·
·
$800
$3.3K
$1.1K
·
·
·
·
·
·
Free Cash Flow
·
·
$-5M
·
·
·
$1M
·
$-181.3K
$-339.6K
·
·
Levered FCF
·
·
$-6M
·
·
·
$926.6K
·
$-202.1K
$-353.4K
·
·
Lucratividade8
Dados anuais de Lucratividade para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
·
·
·
·
·
·
90.6%
·
81.6%
70.3%
33.2%
·
Operating Margin
·
·
-224.0%
·
·
·
-120.8%
·
-227.0%
-4146.1%
-5090.9%
·
Net Margin
·
·
-266.0%
·
·
·
-146.4%
·
-248.9%
-4173.3%
-42426.6%
·
Pretax Margin
·
·
-265.1%
·
·
·
-146.4%
·
-248.9%
-4173.3%
-42426.6%
·
EBITDA Margin
·
·
-217.4%
·
·
·
-120.1%
·
-226.0%
-4142.4%
-5042.7%
·
ROA
·
·
·
·
·
·
-168.5%
·
-254.1%
-490.6%
-1273.3%
·
ROE
·
·
·
·
·
·
58.0%
·
14.6%
50.7%
126.2%
·
ROIC
·
·
·
·
·
·
48.2%
·
12.8%
45.7%
15.8%
·
Liquidez e Solvência4
Dados anuais de Liquidez e Solvência para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
·
·
·
·
·
·
1.0
·
0.0
0.1
0.1
·
Quick Ratio
·
·
·
·
·
·
0.8
·
0.0
0.0
0.1
·
Debt / Equity
·
·
·
·
·
·
0.0
·
·
·
·
·
Interest Coverage
·
·
-7.3
·
·
·
-4.7
·
-30.7
-152.5
-18.6
·
Eficiência3
Dados anuais de Eficiência para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
·
·
·
·
·
·
1.2
·
1.0
0.1
0.0
·
Inventory Turnover
·
·
·
·
·
·
1.9
·
0.7
0.2
·
·
Receivables Turnover
·
·
·
·
·
·
12.7
·
6.3
24.6
8.7
·
Por Ação5
Dados anuais de Por Ação para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
·
·
·
·
·
·
$-0.02
·
$-0.04
$-0.03
$-0.03
·
Revenue / Share
·
·
$1.93
·
·
·
$0.01
·
$0.00
$0.00
$0.00
·
Cash Flow / Share
·
·
$-3.04
·
·
·
$0.01
·
$-0.00
$-0.00
$-0.00
·
Cash / Share
·
·
·
·
·
·
$0.01
·
$0.00
$0.00
$0.00
·
EPS (TTM)
$-214.64
$-30.19
$-67.37
$-17.97
$-0.63
$-1.52
$-0.45
$-0.02
$0.00
$-0.02
$-0.04
·
Taxas de Crescimento3
Dados anuais de Taxas de Crescimento para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue YoY
4.7%
116.3%
267.4%
-80.2%
301.1%
·
·
·
·
·
·
·
Revenue CAGR 3Y
102.6%
16.2%
42.8%
·
·
·
·
·
·
·
·
·
Revenue CAGR 5Y
45.8%
·
·
·
·
·
·
·
·
·
·
·
Avaliação (TTM)5
Dados anuais de Avaliação (TTM) para IVF
Métrica
Tendência
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$7M
$7M
$3M
$822.2K
$4M
$1M
$1M
$494.4K
$282.1K
$50.9K
$11.7K
·
Net Income TTM
$-23M
$-9M
$-8M
$-11M
$-7M
$-8M
$-2M
$-3M
$-702.2K
$-2M
$-5M
·
P/E
-0.0
-1.0
-0.7
-17.0
-3805.7
-1425.8
·
·
·
·
·
·
P / Tangible Book
17.9
3.0
·
·
3984.3
3698.6
·
·
·
·
·
·
Earnings Yield
-28504.6%
-103.5%
-138.6%
-5.9%
-0.03%
-0.07%
·
·
·
·
·
·
Demonstração de Resultados17
Dados trimestrais de Demonstração de Resultados para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue
$2M
$2M
$2M
$2M
$2M
$2M
$2M
$1M
$2M
$2M
$1M
$974.9K
$315.9K
$348.0K
$278.1K
$235.3K
Cost of Revenue
$60.1K
$5.2K
·
·
$3.1K
$4.0K
$-3M
$988.5K
$861.6K
$862.1K
$925.2K
$581.0K
$235.7K
$231.0K
·
$97.6K
Gross Profit
·
·
·
·
·
·
·
·
·
·
·
·
·
$275.5K
·
$126.2K
R&D Expense
·
·
·
·
·
$265.7K
$0
·
·
$4.9K
$5.9K
$2.7K
$83.8K
$73.5K
$73.8K
$175.3K
SG&A Expense
$2M
$2M
$815.5K
$2M
$2M
$2M
$2M
$2M
$3M
$1M
$2M
$1M
$2M
$2M
$3M
$2M
Operating Expenses
$3M
$4M
$-13M
$3M
$5M
$3M
$4M
$3M
$4M
$3M
$3M
$2M
$2M
$3M
$3M
$3M
Operating Income
$-1M
$-2M
$14M
$-2M
$-3M
$-1M
$-2M
$-1M
$-2M
$-2M
$-2M
$-886.3K
$-2M
$-2M
$-3M
$-3M
Interest Expense
·
·
·
·
·
$-311.3K
·
·
·
$-181.3K
$182.0K
$352.1K
$175.2K
$216.6K
$56.1K
$1.8K
Other Non-op
$2M
$-4M
$3M
$-2M
$1M
$-292.7K
$-194.1K
$-301.0K
$-390.3K
$-86.6K
$-463.3K
$-360.3K
$-171.7K
$-244.5K
$-46.7K
$-24.2K
Pretax Income
$944.9K
·
$18M
$-3M
$-2M
$-17M
$-2M
$-2M
$-2M
$-2M
$-2M
$-1M
$-2M
$-3M
$-3M
$-3M
Income Tax
$56.2K
$0
·
·
·
$0
$109.1K
$29.3K
·
$1.8K
$23.0K
$1.9K
$2.9K
·
$2.1K
·
Net Income
$888.7K
$-6M
$2M
$-3M
$-4M
$-17M
$-4M
$-2M
$-2M
$-2M
$-2M
$-1M
$-2M
$-3M
$-3M
$-3M
EPS (Basic)
$0.42
$-3.38
$-188.04
$-39.40
$-364.23
$-3473.93
$-3737.60
$-15.11
$-22.39
$-7.55
$-59.51
$-0.70
$-3.06
$-4.10
$-8.93
$-4.19
EPS (Diluted)
$0.35
$-3.38
$-188.04
$-39.40
$-364.23
$-3473.93
$-3737.60
$-15.11
$-22.39
$-7.55
$-59.51
$-0.70
$-3.06
$-4.10
$-8.93
$-4.19
Shares (Basic)
2,105,595
1,637,859
-5,117,120
3,447,622
9,936
5,010
-417,040
107,949
100,276
211,329
-3,012,396
1,776,898
732,255
622,507
-12,658,109
607,783
Shares (Diluted)
2,592,025
1,637,859
-5,117,120
3,447,622
9,936
5,010
-417,040
107,949
100,276
211,329
-3,012,396
1,776,898
732,255
622,507
-12,658,109
607,783
EBITDA
$-1M
$-1M
·
$-2M
$-3M
$-17M
·
$-1M
$-2M
$-719.4K
·
$-886.3K
$-2M
$-2M
·
$-3M
Balanço Patrimonial23
Dados trimestrais de Balanço Patrimonial para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Cash & Equivalents
$4M
$5M
$2M
$355.9K
$549.2K
$840.4K
$619.5K
$471.6K
$942.9K
$475.1K
$232.4K
$1M
$112.5K
$2M
$90.1K
$285.7K
Receivables
$257.7K
$248.4K
$217.3K
$274.2K
$242.3K
$173.6K
$113.1K
$257.1K
$257.2K
$176.9K
$140.6K
$116.8K
$74.9K
$99.7K
$77.1K
$71.3K
Inventory
$251.3K
$224.6K
$225.3K
$191.8K
$212.6K
$216.5K
$219.8K
$241.5K
$250.1K
$266.5K
$264.5K
$254.2K
$280.0K
$270.9K
$263.6K
$280.1K
Prepaid Expense
$360.8K
$356.8K
$241.1K
$315.0K
$395.3K
$338.6K
$180.9K
$987.3K
$945.9K
$806.5K
$622.3K
$365.2K
$374.7K
$250.9K
$190.2K
$305.2K
Current Assets
$5M
$6M
$3M
$1M
$1M
$2M
$1M
$2M
$2M
$2M
$1M
$2M
$842.1K
$3M
$621.1K
$942.3K
PP&E (Net)
$832.9K
$474.6K
$386.2K
$405.4K
$428.7K
$451.2K
$466.7K
$415.2K
$441.4K
$412.2K
$826.4K
$772.4K
$659.4K
$417.6K
$436.7K
$456.4K
Accum. Depreciation
$532.2K
$497.0K
$459.6K
$428.6K
$397.2K
$365.8K
$335.7K
$308.3K
$282.1K
$256.2K
$233.6K
$212.6K
$192.1K
$172.4K
$153.3K
$134.2K
Goodwill
$9M
$7M
$6M
$6M
$6M
$9M
$6M
$6M
$6M
$6M
$6M
$8M
·
·
·
·
Intangibles
$1M
$1M
$1M
$1M
$2M
$18M
$3M
$3M
$4M
$4M
$4M
$2M
·
·
·
$132.7K
Total Assets
$26M
$25M
$20M
$19M
$19M
$32M
$46M
$17M
$18M
$18M
$19M
$19M
$7M
$6M
$4M
$5M
Accounts Payable
$2M
$2M
$2M
$2M
$2M
$5M
$3M
$3M
$2M
$3M
$2M
$2M
$2M
$2M
$1M
$689.6K
Current Liabilities
$7M
$6M
$10M
$9M
$12M
$19M
$18M
$9M
$8M
$9M
$8M
$5M
$4M
$4M
$3M
$2M
Capital Leases
$2M
$2M
$1M
$2M
$2M
$2M
$1M
$2M
$2M
$3M
$3M
$6M
$4M
$2M
$1M
$2M
Deferred Tax
$56.1K
·
·
·
·
·
$163.1K
·
·
·
·
$1.9K
$1.9K
$1.9K
$1.9K
$1.1K
Other Non-current Liabilities
$79.7K
$79.7K
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Total Liabilities
$9M
$10M
$13M
$13M
$17M
$24M
$26M
$17M
$16M
$18M
$18M
$19M
$8M
$6M
$5M
$3M
Long-term Debt
$2M
$2M
$892.5K
$2M
$5M
·
$7M
·
·
·
·
·
·
·
·
·
Total Debt
$2M
$2M
·
$2M
$5M
·
·
·
·
·
·
·
·
·
·
·
Common Stock
$229
$164
$239
$542
$83
$74
$37
$391
$386
$262
$20
$247
$83
$1.4K
$61
$1.2K
Retained Earnings
$-96M
$-97M
$-91M
$-93M
$-90M
$-85M
$-67M
$-64M
$-62M
$-59M
$-58M
$-56M
$-55M
$-52M
$-50M
$-47M
Stockholders' Equity
$16M
$15M
$7M
$6M
$3M
$3M
$13M
$-23.3K
$1M
$10.2K
$892.8K
$372.8K
$-2M
$88.5K
$-977.6K
$1M
Liabilities + Equity
$26M
$25M
$20M
$19M
$19M
$32M
$46M
$17M
$18M
$18M
$19M
$19M
$7M
$6M
$4M
$5M
Shares Outstanding
2,295,035
1,640,635
477,366
5,423,801
828,110
746,227
3,111
3,906,072
3,864,072
2,618,031
207,711
2,474,756
826,886
13,971,283
608,611
12,165,964
Fluxo de Caixa14
Dados trimestrais de Fluxo de Caixa para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
D&A
$145.6K
$142.7K
$136.4K
$136.7K
$169.7K
$234.5K
$231.8K
$230.5K
$230.3K
$227.0K
$141.6K
$20.5K
$19.7K
$19.1K
$19.9K
$19.7K
Stock-based Comp
·
·
·
·
·
·
·
·
·
·
·
$251.6K
$326.9K
$325.8K
·
$426.1K
Amort. of Intangibles
$110.3K
$105.3K
$105.3K
$105.3K
$138.4K
$204.4K
$204.4K
$204.4K
$204.4K
$204.4K
$120.6K
$0
$0
$0
$452
$453
Other Non-cash
·
$3M
·
·
·
$14M
·
·
·
$1M
·
·
·
$1M
·
·
Operating Cash Flow
$-1M
$-2M
$25.2K
$-2M
$-2M
$-4M
$-617.4K
$-640.8K
$-1M
$-260.6K
$-714.9K
$-1M
$-2M
$-1M
$-1M
$-2M
CapEx
·
·
$11.8K
$8.1K
$8.9K
$14.7K
$78.9K
$0
$55.1K
$49.7K
$75.0K
$108.2K
·
·
$-135
$2.6K
Investing Cash Flow
$-2.2K
$-210.0K
$-3M
$-8.1K
$-15.4K
$-14.7K
$393.1K
$0
$-5.1K
$-24.1K
$33.3K
$-2M
$-261.5K
$-8.4K
$8.6K
$-3.0K
Stock Issued
·
·
$4M
$0
$0
$9M
$0
$0
·
·
$-23.1K
$3M
$20.3K
$3M
$0
$-25.2K
Net Stock Activity
·
·
·
·
·
$9M
·
·
·
·
·
·
·
$3M
·
·
Financing Cash Flow
$-67.8K
$5M
$4M
$2M
$1M
$4M
$494.1K
$169.5K
$2M
$527.4K
$-141.5K
$4M
$-169.9K
$3M
$800.0K
$-25.2K
Net Change in Cash
$-1M
$3M
$2M
$-193.3K
$-291.2K
$99.0K
$269.8K
$-471.3K
$467.8K
$242.7K
$-823.1K
$943.1K
$-2M
$2M
$-195.6K
$-2M
Taxes Paid
·
·
·
·
·
·
·
·
·
·
·
·
·
$800
$0
$-2.0K
Free Cash Flow
·
·
·
·
·
$-4M
·
·
·
$-310.3K
·
·
·
·
·
·
Levered FCF
·
·
·
·
·
·
·
·
·
$-491.8K
·
·
·
·
·
·
Lucratividade8
Dados trimestrais de Lucratividade para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Gross Margin
·
·
·
·
·
·
·
·
·
·
·
·
·
79.1%
·
53.6%
Operating Margin
-59.3%
-79.0%
·
-93.1%
-160.4%
-1044.9%
·
-90.7%
-103.6%
-60.0%
·
-90.9%
-654.0%
-662.7%
·
-1073.2%
Net Margin
40.8%
-274.9%
·
-150.5%
-283.6%
-1063.0%
·
-113.8%
·
-101.3%
·
-128.1%
-709.2%
-733.0%
·
-1083.5%
Pretax Margin
43.4%
·
·
-150.5%
-172.2%
-1063.0%
·
-111.7%
-122.2%
-101.2%
·
-127.9%
-708.3%
·
·
-1083.5%
EBITDA Margin
-59.3%
-71.9%
·
-93.1%
-160.4%
-1030.6%
·
-90.7%
-103.6%
-45.6%
·
-90.9%
-654.0%
-657.2%
·
-1073.2%
ROA
3.9%
-19.6%
·
-14.8%
-28.5%
-69.5%
·
-8.9%
·
-13.1%
·
-10.3%
-34.3%
-34.8%
·
-39.8%
ROE
9.3%
-60.3%
·
-90.8%
-264.6%
-1040.4%
·
-933.2%
·
-3237.7%
·
-150.4%
-271.4%
-89.8%
·
-140.0%
ROIC
-6.7%
·
·
·
·
·
·
5679.2%
·
-9330.0%
·
-238.1%
121.3%
·
·
·
Liquidez e Solvência5
Dados trimestrais de Liquidez e Solvência para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Current Ratio
0.7
0.9
·
0.1
0.1
0.1
·
0.2
0.3
0.2
·
0.4
0.2
0.6
·
0.6
Quick Ratio
0.6
0.8
·
0.1
0.1
0.1
·
0.1
0.2
0.1
·
0.2
0.0
0.5
·
0.2
Debt / Equity
0.1
0.1
·
0.3
1.8
·
·
·
·
·
·
·
·
·
·
·
LT Debt / Equity
0.0
0.0
·
0.2
0.4
·
·
·
·
·
·
·
·
·
·
·
Interest Coverage
·
·
·
·
·
55.0
·
·
·
-5.2
·
-2.5
-11.8
-10.6
·
-1434.1
Eficiência3
Dados trimestrais de Eficiência para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Asset Turnover
0.1
0.1
·
0.1
0.1
0.1
·
0.1
0.2
0.1
·
0.1
0.0
0.0
·
0.0
Inventory Turnover
0.3
0.0
·
·
·
4.4
·
4.0
3.3
3.2
·
·
·
0.2
·
0.3
Receivables Turnover
8.7
9.6
·
6.6
7.5
9.3
·
7.7
11.1
11.4
·
10.4
4.8
4.4
·
3.9
Por Ação5
Dados trimestrais de Por Ação para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Book Value / Share
$7.19
$9.16
·
$1.08
$3.18
$4.47
·
$-0.01
$0.35
$0.00
·
$0.15
$-2.06
$0.01
·
$0.11
Revenue / Share
$0.84
$1.23
·
$0.51
$4.69
$1.18
·
$0.37
$0.51
$0.41
·
$0.55
$0.43
$0.03
·
$0.02
Cash Flow / Share
·
$-1.17
·
·
·
$-2.55
·
·
·
$-0.07
·
·
·
$-0.09
·
·
Cash / Share
$1.63
$2.99
·
$0.07
$0.66
$1.13
·
$0.12
$0.24
$0.18
·
$0.43
$0.14
$0.16
·
$0.02
EPS (TTM)
$-406.66
$-3880.94
·
$-41.71
$-63.33
$-57.58
·
$-45.75
$-33.70
$-15.41
·
$-12.05
$-15.97
$-13.14
·
$-9.28
Avaliação (TTM)13
Dados trimestrais de Avaliação (TTM) para IVF
Métrica
Tendência
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Q3 2023
Q2 2023
Q1 2023
Q4 2022
Q3 2022
Revenue TTM
$8M
$7M
·
$7M
$7M
$6M
·
$6M
$5M
$3M
·
$2M
$1M
$892.1K
·
$762.9K
Net Income TTM
$-12M
$-30M
·
$-27M
$-27M
$-23M
·
$-7M
$-7M
$-8M
·
$-9M
$-10M
$-11M
·
$-10M
Market Cap
$4M
$4M
·
$4M
$2M
$4M
·
$100M
$117M
$107M
·
$70M
$119M
$6.43B
·
$9.29B
Enterprise Value
$2M
$1M
·
$6M
$6M
·
·
·
·
·
·
·
·
·
·
·
P/E
-0.0
-0.0
·
-0.0
-0.0
-0.1
·
-0.6
-0.9
-2.6
·
-2.4
-9.0
-35.0
·
-82.2
P/S
0.6
0.6
·
0.6
0.3
0.7
·
17.2
24.8
33.1
·
37.6
113.9
7205.5
·
12170.3
P/B
0.3
0.3
·
0.7
0.8
1.3
·
-4282.0
85.7
10487.6
·
188.8
-69.8
72659.6
·
7213.2
P / Tangible Book
0.7
0.6
·
·
·
·
·
·
·
·
·
·
·
72659.6
·
8042.2
P / Cash Flow
·
-2.3
·
·
·
-1.3
·
·
·
-408.7
·
·
·
-5597.0
·
·
P / FCF
·
·
·
·
·
-1.3
·
·
·
-343.3
·
·
·
·
·
·
EV / EBITDA
-1.8
-1.0
·
-3.5
-2.2
·
·
·
·
·
·
·
·
·
·
·
EV / Revenue
0.3
0.2
·
0.9
1.0
·
·
·
·
·
·
·
·
·
·
·
Earnings Yield
-21403.2%
-142681.6%
·
-5488.2%
-2398.9%
-959.7%
·
-179.0%
-111.4%
-37.9%
·
-42.4%
-11.1%
-2.9%
·
-1.2%
Demonstrações Financeiras
Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
2025-12-31
2024-12-31
2024-03-31
2023-12-31
2023-09-30
Receita
$7M
$7M
—
$3M
—
Margem Operacional %
—
—
—
-224.0%
—
Lucro líquido
$-23M
$-9M
—
$-8M
—
EPS Diluído
$-214.64
$-3782.65
—
$-67.37
—
Fluxo de Caixa
2025-12-31
2024-12-31
2024-03-31
2023-12-31
2023-09-30
Fluxo de caixa livre
—
—
—
$-5M
—
Minhas Métricas
Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F)
2 declarantes · $1 total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
Novas posições
Posições encerradas
Aumentou
Diminuído
Variação líquida de ações
0
(-1 vs trimestre anterior)
1
(-8 vs trimestre anterior)
0
(0 vs trimestre anterior)
0
(0 vs trimestre anterior)
-13
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+
2 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Usamos cookies para analisar o tráfego do site e melhorar sua experiência.
Saiba mais
Preferências de cookies
NecessáriosEssenciais para funções básicas: idioma, tema, memória de consentimento.
AnalíticosNos ajudam a entender como os visitantes usam o site. Dados de tráfego anônimos.
MarketingMedir a eficácia de anúncios e exibir anúncios relevantes. Cookies do Google Ads.
PersonalizaçãoConteúdo personalizado e recomendações de anúncios com base na sua navegação.